Market Access News | pharmaphorum

News

AbbVie has filed for FDA approval of a new front-line therapy for chronic lymphocytic leukaemia that it thinks could be 'practice changing."

News

The disruption at the FDA continues with the departure of CBER director Vinay Prasad, less than three months after taking on the role.

News

After some initial confusion, it has been confirmed that the 15% tariff rate on US imports from the EU will extend to pharmaceuticals.

News

Bayer files its oral HER2+ lung cancer drug in China, as it extends a race to market with rival Boehringer Ingelheim.

News

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy Kisunla has paid off.

News

AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo